# Multi-centre Clinical Trial on Hormone Replacement Treatment in China

> **NCT01698164** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 1200 (estimated)

## Conditions studied

- Menopausal Syndrome
- Cardiovascular Disease
- Osteoporosis
- Breast Cancer

## Interventions

- **DRUG:** estradiol plus MPA
- **DRUG:** Ximingting Tablet
- **DRUG:** estradiol plus progesterone

## Key facts

- **NCT ID:** NCT01698164
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2012-10
- **Final completion:** —
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2012-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01698164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01698164, "Multi-centre Clinical Trial on Hormone Replacement Treatment in China". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01698164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*